| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-02-13 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | $15.30M | $897.13K | $7.68M | $2.91M | $332.03K |
| R&D | – | $6.32M | $764.19K | $5.29M | – | – |
| SG&A | – | $8.99M | $132.94K | $2.39M | $2.84M | $251.71K |
| Operating Income | – | -$15.30M | -$897.13K | -$7.68M | -$2.91M | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | $94.82K | $599.16K | -$16.87K |
| Net Income | -$19.92M | -$7.73M | -$572.21K | -$7.29M | -$667.74K | -$315.55K |
| EPS (basic) | – | -18.1500 | -97.9000 | -1248.6400 | – | – |
| EPS (diluted) | – | -18.1500 | -97.9000 | -1248.6400 | – | – |
| Shares (diluted) | – | $579.43K | $5.84K | $5.84K | – | – |